Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-08

Clinical Trial Update: Safety and Efficacy Study of a Eye Drop for Eye Allergy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of an eye drop for allergic conjunctivitis completed, with trial results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified Eye Drop

Snippet

Sponsor: Vistakon Pharmaceuticals | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2011-12-08